Penbrook Management LLC lowered its stake in OncoCyte Co. ( NASDAQ:OCX – Get Rating ) by 63.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 207,675 shares of the company's stock after selling 355,675 shares during the period. Penbrook Management LLC owned 0.18% of OncoCyte worth $67,000 at the end of the most recent quarter. A number of other hedge funds have also recently added to or reduced their stakes in OCX.

https://www.dailypolitical.com/2023/04/01/penbrook-management-llc-has-67000-stock-holdings-in-oncocyte-co-nasdaqocx.html

#dailypolitical